Arkolith/Insider Trading/FIXX/Form 4

Seymour Albert

See Remarks, DirectorHomology Medicines, Inc. (FIXX) · full profile →Form 4 · filed Sep 8, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 6, 2023Option exercise(M)5K——152K
Sep 6, 2023Sell(S)1K$1.15$2K151K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 6, 2023Option exercise(M)5K—$09K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-047302) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML